Connective Tissue Research

Connective Tissue Research is a peer-reviewed journal published by Taylor & Francis for work on the extracellular matrix and on the cells that build, maintain and dismantle it.《结缔组织研究》由 Taylor & Francis 出版，是一份同行评审期刊，刊载细胞外基质研究，也刊载关于构建、维持与重塑基质的细胞的论文。

Founded in 1972, it devotes itself to bone, cartilage, tendon, ligament, muscle, dentin, skin and teeth, and to matrix-rich organs such as the eye, blood vessels, kidney and lung.该刊创刊于 1972 年，关注骨与软骨、肌腱与韧带，也关注肌肉与皮肤及牙齿，并覆盖眼与血管，也包括肾与肺这类富含基质的器官。

Its 2025 Journal Impact Factor is 1.9, the five-year figure is 2.6, and six issues appear each year.其 2025 年影响因子为 1.9，五年影响因子为 2.6，每年出版 6 期。

Scope

• The stated aim is to present original and significant research across all basic areas of connective tissue and matrix biology, without narrowing the field to one organ system.刊物自述的目标是刊载结缔组织与基质生物学各基础方向的原创性重要研究，不把视野收窄到单一器官系统。
• Contributions come from biochemistry, cell and molecular biology, immunology, structural biology, biophysics, biomechanics and regenerative medicine, an explicitly interdisciplinary mix the editors invite.稿件来自生物化学与细胞分子生物学，也来自免疫学与结构生物学，还有生物物理学与生物力学及再生医学，编委会明确欢迎这种跨学科组合。
• Matrix macromolecules form a standing subject, covering collagen and elastin biosynthesis, proteoglycan and glycosaminoglycan structure, and the cross-linking enzymes that lock fibrils together.基质大分子是长期主题，涵盖胶原与弹性蛋白的生物合成、蛋白聚糖与糖胺聚糖的结构，以及把纤维彼此交联的酶类。
• Assembly receives as much attention as synthesis, from intracellular procollagen processing to fibrillogenesis, supramolecular organisation and the deposition of mineral within a collagen scaffold.组装与合成受到同等关注，从细胞内前胶原加工到原纤维形成，再到超分子组织以及矿物在胶原支架内的沉积。
• Degradation and turnover are treated as active biology, with matrix metalloproteinases, ADAMTS proteinases and cathepsins read in the context of remodelling rather than as isolated enzymes.降解与周转被视为主动的生物学过程，基质金属蛋白酶与 ADAMTS 蛋白酶及组织蛋白酶被放在重塑语境中解读，不只作为孤立的酶学对象。
• Cell-matrix adhesion and mechanotransduction run through the pages, with integrins, discoidin domain receptors and focal adhesion signalling linked to cytoskeletal tension and gene expression.细胞与基质的黏附以及力学信号转导贯穿刊物内容，整合素与盘状结构域受体及黏着斑信号被联系到细胞骨架张力与基因表达。
• Skeletal biology covers osteoblast and osteoclast differentiation, the mineralisation of bone and dentin, and the matrix defects behind inherited skeletal disease.骨骼生物学覆盖成骨细胞与破骨细胞的分化，也覆盖骨与牙本质的矿化，还包括遗传性骨病背后的基质缺陷。
• Cartilage work spans chondrocyte differentiation in the growth plate, the zonal architecture of articular cartilage, and the matrix catabolism that accompanies osteoarthritis.软骨研究涉及生长板中的软骨细胞分化、关节软骨的分层结构，以及伴随骨关节炎的基质分解代谢。
• Fibrocartilage, enthesis, tendon and ligament studies ask how a tissue tuned for tensile load fails, repairs and can be reconstructed.纤维软骨与附着点以及肌腱与韧带的研究，追问一类为拉伸载荷而调校的组织怎样失效，怎样修复，又怎样重建。
• Craniofacial and dental papers deal with periodontal ligament, cementum, enamel matrix and the mineralised tissues of the tooth.颅面与牙科论文处理牙周膜与牙骨质，也处理釉质基质以及牙齿的矿化组织。
• Skin and wound healing appear regularly, including dermal repair, scar formation, fibrosis and the matrix of the vessel wall, heart valve, kidney and lung.皮肤与创面愈合是常见题目，涉及真皮修复与瘢痕形成，也涉及纤维化，还包括血管壁与心脏瓣膜及肾与肺的基质。
• Development, growth, ageing and biomineralisation give the journal a life-course frame, so papers on embryonic matrix and on aged tissue sit side by side.发育与生长、衰老与生物矿化给刊物一个生命历程的框架，胚胎期基质与老年组织的论文因此并列出现。
• Method papers are welcome when they change what can be measured, from molecular genetics and advanced imaging to mechanical testing, biomaterials and tissue-engineered constructs.能改变可测量范围的方法学论文同样受欢迎，从分子遗传学与先进成像，到力学测试与生物材料及组织工程构建体。
• Besides original articles the journal carries topical reviews, and occasionally the proceedings of a conference held in an area of special interest.除原创论文外，刊物还刊登专题综述，偶尔也刊登在特定兴趣领域召开的会议论文集。
• A single issue can place a cartilage biomechanics study next to a dental mineralisation paper, a juxtaposition the editors treat as a feature rather than a fault.同一期里可能出现软骨生物力学研究与牙科矿化论文相邻的情形，编委会把这种并置视为特色，不当作缺陷。

History

• The first volume appeared in 1972 under Gordon and Breach Science Publishers of New York, at a time when connective tissue was still treated as an anatomical category rather than a molecular programme.首卷于 1972 年由纽约的 Gordon and Breach Science Publishers 出版，当时结缔组织仍被视为解剖学类别，尚未被当作分子层面的研究纲领。
• Early volumes carried a different identifier, 0091-1690, which the National Library of Medicine now carries as an invalid number, the current print identifier being 0300-8207.早期卷次使用另一个刊号 0091-1690，美国国家医学图书馆现将其记为失效号码，现行印刷刊号为 0300-8207。
• Indexing followed quickly, with MEDLINE and Index Medicus coverage beginning at volume 2 in 1973 and continuing to the present day.收录随即跟上，MEDLINE 与 Index Medicus 自 1973 年第 2 卷起覆盖该刊，并延续至今。
• Those decades show connective tissue studied mainly through histology, electron microscopy and tissue chemistry, the working methods of matrix science before recombinant tools and monoclonal antibodies reshaped it.那几十年里，结缔组织主要通过组织学与电子显微镜及组织化学被研究，那是重组技术与单克隆抗体重塑该领域之前的工作方法。
• The title had long since moved past a single volume a year, and in 1990 volumes 24 and 25 appeared within the same twelve months, with volume 26 opening in 1991.刊物早已不再一年只出一卷，1990 年同一十二个月内出现过第 24 卷与第 25 卷，第 26 卷则从 1991 年开始。
• The scope shifted with the field, from descriptive chemistry toward gene regulation, receptor biology and mechanical signalling in matrix-producing cells.办刊范围随学科转向，从描述性化学走向基质生成细胞中的基因调控与受体生物学及力学信号。
• Ownership changed in 2001, when Taylor & Francis took over the Gordon and Breach publishing business, and copyright pages of that era already described the imprint as part of the group.2001 年出版权易手，Taylor & Francis 接手 Gordon and Breach 的出版业务，而那一时期的版权页已把该印记描述为集团成员。
• A merger with Informa in 2004 produced the Informa Healthcare imprint, the name the National Library of Medicine still lists as the journal's current imprint in London.2004 年与 Informa 合并后产生 Informa Healthcare 印记，美国国家医学图书馆至今仍把伦敦的这个名字列为该刊的现行出版印记。
• Electronic publication brought the online ISSN 1607-8438 alongside the print number, and the title later settled directly under the Taylor & Francis imprint.电子出版带来在线刊号 1607-8438，与印刷刊号并行，此后刊物直接归入 Taylor & Francis 印记之下。
• The schedule is now six issues a year, and volume 66 closed in 2025 with issue 6, a rhythm that suits a field publishing roughly sixty articles annually.现行刊期为每年 6 期，第 66 卷于 2025 年以第 6 期收尾，这一节奏与每年约 60 篇论文的规模相称。
• Access moved to a hybrid model under the Open Select programme, so authors may pay for immediate open access while subscription publication remains the default.获取方式转为 Open Select 计划下的混合模式，作者可付费选择立即开放获取，订阅式出版仍是默认路径。
• Citation metrics have drifted downward since 2022, from 3.342 to 2.8 in 2023, 2.1 in 2024 and 1.9 in 2025, against a five-year value of 2.6.引用指标自 2022 年以来逐步回落，从 3.342 降至 2023 年的 2.8 与 2024 年的 2.1，2025 年为 1.9，五年影响因子为 2.6。
• Roughly a tenth of recent articles are gold open access, and the journal reports an acceptance rate near 14 percent with about three weeks to a first decision.近期论文约一成以金色开放获取方式发表，刊物公布接收率约 14%，初审时间约三周。

Editors

• Gary Balian, professor emeritus at the University of Virginia, holds the editor-in-chief position, working from the School of Medicine's orthopaedic research and biochemistry and molecular genetics units.主编由弗吉尼亚大学荣休教授（Gary Balian）担任，其工作依托该校医学院的骨科研究与生物化学及分子遗传学单位。
• His masthead address sits in Charlottesville, Virginia, and the same entry names an editorial assistant, Elizabeth Lux Feinberg, at the Cardiovascular Research Institute of Northwestern University.编委页上的通讯地址把主编列在弗吉尼亚州夏洛茨维尔，同一处还列出编辑助理（Elizabeth Lux Feinberg），其所在为西北大学心血管研究所。
• Arthur Veis of Northwestern University is recorded as editor emeritus, with cell and molecular biology as his listed field.西北大学的（Arthur Veis）被列为荣休主编，其名下注明的领域是细胞与分子生物学。
• Gary Gibson, who heads cell biology at the Bone and Joint Center of Henry Ford Hospital in Detroit, carries the separate title of associate editor for reviews.底特律 Henry Ford Hospital 骨与关节中心的细胞生物学负责人（Gary Gibson），另有一个综述副主编的头衔。
• More than thirty associate editors complete the board, drawn largely from North American medical schools and engineering departments.30 余位副主编构成编委主体，多来自北美的医学院与工程院系。
• Orthopaedic surgery departments dominate the list, among them Michigan, Pennsylvania, Duke, Rochester and Brown, which reflects how much of the field now sits inside clinical bone and joint units.名单以骨科系居多，密歇根大学与宾夕法尼亚大学在列，杜克大学与罗切斯特大学也在其中，反映出该领域大量研究已置身临床骨与关节单元之内。
• Dental and craniofacial expertise is represented through schools of dental medicine and oral biology, including Boston University, Illinois at Chicago and McGill.牙科与颅面专长由牙医学院与口腔生物学系承担，波士顿大学与伊利诺伊大学芝加哥分校在列，麦吉尔大学也在其中。
• Biomedical engineering and materials science seats widen the board beyond clinical departments, with appointments at Virginia Tech, Penn State, North Carolina and McGill's materials engineering group.生物医学工程与材料科学的席位把编委扩展到临床科室之外，弗吉尼亚理工与宾州州立均有任职，北卡罗来纳大学与麦吉尔材料工程组同样在列。
• The board is not confined to the United States, since members are based in Britain, Canada, Italy, Japan, Israel, Thailand and the United Arab Emirates.编委并不限于美国，成员分布于英国与加拿大，也有意大利与日本的学者，以色列与泰国及阿联酋同样有代表。
• Masthead revisions carry a date, and the current listing shows an update of 22 October 2024, which lets readers judge how fresh the names are.编委名单的修订带日期，现行版本标注的更新日为 2024 年 10 月 22 日，读者据此可以判断名单的新旧。
• Manuscripts enter through the publisher's online submission site under the journal code ICTS, where the instructions for authors and declarations of originality are held.稿件经出版商在线投稿系统进入，刊物代码为 ICTS，作者须知与原创性声明都放在那里。
• The board also runs an annual prize and issues calls for papers, such as the 2025 Connective Tissue Research Award and a collection on osteoarthritis research in the twenty-first century.编委会还主持年度奖项与专题征稿，例如 2025 年 Connective Tissue Research Award，以及围绕二十一世纪骨关节炎研究的专题合集。
• Topical reviews are routed to that reviews desk rather than to the general pool of associate editors, and conference proceedings appear only occasionally, chosen from meetings the board considers of special interest.专题综述交由这个综述岗处理，不进入副主编的通用分流，会议论文集只是偶尔出现，选自编委会认为有特殊意义的会议。